MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer.
- Several lines of evidence have suggested that estrogen receptor alpha (ERalpha)-negative breast tumors, which are highly aggressive and nonresponsive to hormonal therapy, arise from ERalpha-positive precursors through different molecular pathways. Because microRNAs (miRNAs) modulate gene expression, we hypothesized that they may have a role in ER-negative tumor formation.
- Tipo de documento:
- Referencia
- Referencia del producto:
- 07-702
- Nombre del producto:
- Anti-FOXO3a/FKHRL1 Antibody